Fig. 1. GMS can stratify recurrence and survival according to disease risk in the validation cohort.
a–c Kaplan–Meier curve showing associations between GMS and DFS in the a full cohort (n = 862), b “low-risk” colorectal cancer (n = 499) and c “high-risk” colorectal cancer (n = 363). d–e Kaplan–Meier curve showing associations between GMS and RFS in the a full cohort (n = 862), b “low-risk” colorectal cancer (n = 499) and c “high-risk” colorectal cancer (n = 363).